Armistice Capital’s InMed Pharmaceuticals INM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,348
| Closed | -$97.2K | – | 317 |
|
|
2024
Q1 | $97.2K | Buy |
13,348
+3,050
| +30% | +$22.2K | ﹤0.01% | 303 |
|
|
2023
Q4 | $85.7K | Buy |
+10,298
| New | +$85.7K | ﹤0.01% | 255 |
|
|
2023
Q1 | – | Sell |
-4,858
| Closed | -$196K | – | 238 |
|
|
2022
Q4 | $196K | Buy |
4,858
+358
| +8% | +$14.5K | ﹤0.01% | 153 |
|
|
2022
Q3 | $593K | Buy |
4,500
+2,588
| +135% | +$341K | 0.01% | 145 |
|
|
2022
Q2 | $450 | Buy |
+1,912
| New | +$450 | 0.01% | 138 |
|
|
2021
Q4 | – | Sell |
-1,020
| Closed | -$893K | – | 157 |
|
|
2021
Q3 | $893K | Sell |
1,020
-760
| -43% | -$665K | 0.02% | 121 |
|
|
2021
Q2 | $2.83M | Buy |
1,780
+1,310
| +279% | +$2.08M | 0.05% | 100 |
|
|
2021
Q1 | $776K | Buy |
+470
| New | +$776K | 0.02% | 102 |
|